Horizon Pharma CEO Timothy Walbert's 2018 pay jumps 617% to $17M
Horizon Pharma reports 2018 executive compensation
By ExecPay News
Published: March 18, 2020
Horizon Pharma reported fiscal year 2018 executive compensation information on March 18, 2020.
In 2018, seven executives at Horizon Pharma received on average a compensation package of $6.7M, a 374% increase compared to previous year.
Timothy P. Walbert, Chief Executive Officer, received $17M in total, which increased by 617% compared to 2017. 81% of Walbert's compensation, or $14M, was in stock awards. Walbert also received $2M in non-equity incentive plan, $1.1M in salary, as well as $160K in other compensation.
For fiscal year 2018, the median employee pay was $207,196 at Horizon Pharma. Therefore, the ratio of Timothy P. Walbert's pay to the median employee pay was 81 to one.
Paul W. Hoelscher, Chief Financial Officer, received a compensation package of $7M, which increased by 656% compared to previous year. 83% of the compensation package, or $5.8M, was in stock awards.
Robert F. Carey, Executive Vice President, Chief Business Officer, earned $7M in 2018, a 662% increase compared to previous year.
Shao-Lee Lin, Chief Scientific Officer, received $7M in 2018.
Jeffrey W. Sherman, M.D., FACP, Chief Medical Officer, earned $3.7M in 2018.
Barry J. Moze, Chief Administrative Officer, received $2.7M in 2018, which increases by 180% compared to 2017.
Vikram Karnani, Executive Vice President, Chief Commercial Officer, earned $2.5M in 2018, a 230% increase compared to previous year.
Related executives
Vikram Karnani
Horizon Pharma
Executive Vice President, Chief Commercial Officer
Jeffrey FACP
Horizon Pharma
Chief Medical Officer
Timothy Walbert
Horizon Pharma
Chief Executive Officer
Paul Hoelscher
Horizon Pharma
Chief Financial Officer
Shao-Lee Lin
Horizon Pharma
Chief Scientific Officer
Robert Carey
Horizon Pharma
Former Executive Vice President, Chief Business Officer
Barry Moze
Horizon Pharma